| No. (n/N) (%) |
---|---|
Patients’ clinical characteristics (N = 18) | |
Age | |
 Median (range) | 63.2 (55–76) |
 Age > 60 years | 11/18 (61) |
Sex. female | 12/18 (67) |
Smoking | 4/18 (22) |
Positive serum tumor markers | |
 CEA | 6/18 (33) |
 CA199 | 9/18 (50) |
 CYFRA 21-1 | 2/18 (11) |
 NSE | 0/18 (0) |
Location | |
 RLL/RUL/RML | 9/18 (50) |
 LLL/LUL | 9/18 (50) |
Size (cm) | |
 Median (range) | 3.1 (1.1–6.6) |
pTNM classification | |
 Stage I/II | 12/18 (67) |
 Stage III/IV | 6/18 (33) |
Follow-up (M) | |
 Median (range) | 31 (4–96) |
 Died | 3/16 (19) |
 Alive | 13/16 (81) |
 Not available | 2/16 (12.5) |